#AACR23 (Photo: Nicole DeFeudis for Endpoints News)

AACR roundup: Merus eyes ac­cel­er­at­ed ap­proval; Im­muneer­ing ac­cel­er­ates RAS drug

Merus of­fered an in­ter­im look at an on­go­ing Phase I/II tri­al for its bis­pe­cif­ic an­ti­body petosem­tam­ab on Mon­day, show­ing an over­all …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.